share_log

美诺华:全资子公司获得西格列汀二甲双胍片药品注册证书

Gelonghui Finance ·  May 22 05:41
格隆汇5月22日|美诺华公告,全资子公司美诺华天康于近日收到国家药监局核准签发的两个剂型西格列汀二甲双胍片《药品注册证书》。
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment